Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2950
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVan Vlierberghe, H-
dc.contributor.authorLeroux-Roels, G-
dc.contributor.authorBourgeois, N-
dc.contributor.authorNevens, F-
dc.contributor.authorColle, I-
dc.contributor.authorHenrion, J-
dc.contributor.authorDelwaide, J-
dc.contributor.authorHorsmans, Y-
dc.contributor.authorBrenard, R-
dc.contributor.authorMichielsen, P-
dc.contributor.authorROBAEYS, Geert-
dc.contributor.authorBRUCKERS, Liesbeth-
dc.date.accessioned2007-11-20T14:39:53Z-
dc.date.available2007-11-20T14:39:53Z-
dc.date.issued2000-
dc.identifier.citationGASTROENTEROLOGY, 118(4). p. A1496-A1497-
dc.identifier.issn0016-5085-
dc.identifier.urihttp://hdl.handle.net/1942/2950-
dc.language.isoen-
dc.publisherW B SAUNDERS CO-
dc.titleDaily induction treatment with alfa2b interferon in naive chronic hepatitis C patients results in a higher early response, a controlled multicenter randomized trial.-
dc.typeJournal Contribution-
dc.identifier.epageA1497-
dc.identifier.issue4-
dc.identifier.spageA1496-
dc.identifier.volume118-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notesState Univ Ghent Hosp, B-9000 Ghent, Belgium. Ctr Biostat, Diepenbeek, Belgium.-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.isi000086784101842-
item.fulltextNo Fulltext-
item.contributorVan Vlierberghe, H-
item.contributorLeroux-Roels, G-
item.contributorBourgeois, N-
item.contributorNevens, F-
item.contributorColle, I-
item.contributorHenrion, J-
item.contributorDelwaide, J-
item.contributorHorsmans, Y-
item.contributorBrenard, R-
item.contributorMichielsen, P-
item.contributorROBAEYS, Geert-
item.contributorBRUCKERS, Liesbeth-
item.fullcitationVan Vlierberghe, H; Leroux-Roels, G; Bourgeois, N; Nevens, F; Colle, I; Henrion, J; Delwaide, J; Horsmans, Y; Brenard, R; Michielsen, P; ROBAEYS, Geert & BRUCKERS, Liesbeth (2000) Daily induction treatment with alfa2b interferon in naive chronic hepatitis C patients results in a higher early response, a controlled multicenter randomized trial.. In: GASTROENTEROLOGY, 118(4). p. A1496-A1497.-
item.accessRightsClosed Access-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.